Our results showed general safety of LipRSV, except for mixed liposomes, which caused hemolysis
One of the few peptides with full regulatory approval and extensive clinical data
Andrew Kraftson, a clinical associate professor at the University of Michigan Medical School, said that he had to stop a patient from continuing on the medications because the person wanted to keep losing weight, even when there was no clear medical benefit to doing so
In obesity and T2D, the depletion of beneficial taxa allows the expansion of potentially harmful, endotoxin-producing bacteria beyond physiological equilibrium (9092)
So the fact that adverse-event discontinuation was numerically lower than placebo does not mean taking 4 mg felt like taking nothing
After 30, something shifts